BioSpace.com

Biotech and Pharmaceutical
News & Jobs
Biotechnology and Pharmaceutical ChannelMedical Device and Diagnostics ChannelClinical Research Channel
By: Benzinga
January 03, 2013 at 13:43 PM EST
UPDATE: JP Morgan Initiates Cerner at Overweight on Leadership, Outlook
JP Morgan initiated coverage on Cerner (NASDAQ: CERN ) with an Overweighr rating and a $93 price target JP Morgan commented, "In the large hospital market (>200 beds), Cerner has ~21% market share of clinical systems, just behind privately-held Epic. Cerner has been gaining share in recent years, improving from
Related Stocks:
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Six Financial
Postage Rates Bots go here